{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:47:52Z","timestamp":1792180072787,"version":"4.4.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32172194"],"award-info":[{"award-number":["32172194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304312"],"award-info":[{"award-number":["82304312"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFB312"],"award-info":[{"award-number":["2023AFB312"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bioorg.2023.106933","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T10:59:14Z","timestamp":1697885954000},"page":"106933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Recent advance of ATP citrate lyase inhibitors for the treatment of cancer and related diseases"],"prefix":"10.1016","volume":"142","author":[{"given":"Jian-Jia","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang-Shuang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106933_b0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2023.106933_b0010","doi-asserted-by":"crossref","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2023.106933_b0015","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1158\/0008-5472.CAN-11-4112","article-title":"ATP-citrate lyase: a key player in cancer metabolism","volume":"72","author":"Zaidi","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2023.106933_b0020","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1021\/jm2005805","article-title":"The lipogenesis pathway as a cancer target","volume":"54","author":"Abramson","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2023.106933_b0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2019.12.010","article-title":"ATP citrate lyase: A central metabolic enzyme in cancer","volume":"471","author":"Icard","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2023.106933_b0035","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1038\/sj.onc.1208773","article-title":"ATP citrate lyase is an important component of cell growth and transformation","volume":"24","author":"Bauer","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2023.106933_b0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hbpd.2020.05.010","article-title":"ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt\/beta-catenin signaling pathway","volume":"20","author":"Han","year":"2021","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.bioorg.2023.106933_b0045","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1038\/s41467-019-12194-6","article-title":"Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis","volume":"10","author":"Kumari","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2023.106933_b0050","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.molcel.2013.07.002","article-title":"Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth","volume":"51","author":"Lin","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2023.106933_b0055","doi-asserted-by":"crossref","unstructured":"J. Puccini, J. Wei, L. Tong, D. Bar-Sagi. Cytoskeletal association of ATP citrate lyase controls the mechanodynamics of macropinocytosis. Proc. Natl. Acad. Sci. U S A. 120(2023) 2213.","DOI":"10.1073\/pnas.2213272120"},{"issue":"2021","key":"10.1016\/j.bioorg.2023.106933_b0060","article-title":"SIRT6 represses invasive cancer cell phenotypes through ATP Citrate Lyase (ACLY)-dependent histone acetylation","volume":"12","author":"Zheng","year":"1460","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bioorg.2023.106933_b0065","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-019-1094-6","article-title":"An allosteric mechanism for potent inhibition of human ATP-citrate lyase","volume":"568","author":"Wei","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2023.106933_b0070","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1021\/jm980091z","article-title":"ATP-Citrate Lyase as a target for hypolipidemic intervention. 2. synthesis and evaluation of (3R*,5S*)-\u03c9-Substituted-3-carboxy-3,5-dihydroxyalkanoic acids and Their \u03b3-Lactone prodrugs as inhibitors of the enzyme in vitro and in vivo","volume":"41","author":"Gribble","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0075","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.bmcl.2007.03.017","article-title":"2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors","volume":"17","author":"Li","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106933_b0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ajhp\/zxaa352","article-title":"Bempedoic acid: Review of a novel therapy in lipid management","volume":"78","author":"Delevry","year":"2021","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.bioorg.2023.106933_b0085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40265-020-01308-w","article-title":"Bempedoic Acid: First Approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2023.106933_b0090","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.celrep.2019.04.112","article-title":"Adipocyte ACLY facilitates dietary carbohydrate handling to maintain metabolic homeostasis in females","volume":"27","author":"Fernandez","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2023.106933_b0095","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.apsb.2022.06.011","article-title":"Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia","volume":"13","author":"Xie","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2023.106933_b0100","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ejmech.2018.09.001","article-title":"ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism","volume":"157","author":"Granchi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/13543776.2022.2067478","article-title":"ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective","volume":"32","author":"Granchi","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2023.106933_b0110","doi-asserted-by":"crossref","first-page":"27418","DOI":"10.1074\/jbc.M109.078667","article-title":"Identification of the Citrate-binding Site of Human ATP-Citrate Lyase Using X-ray Crystallography","volume":"285","author":"Sun","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0115","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1107\/S1744309111028363","article-title":"ADP-Mg2+ bound to the ATP-grasp domain of ATP-citrate lyase","volume":"67","author":"Sun","year":"2011","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.bioorg.2023.106933_b0120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41586-019-1095-5","article-title":"Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle","volume":"568","author":"Verschueren","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2023.106933_b0125","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/jcp.22895","article-title":"Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)\/AKT pathways","volume":"227","author":"Hanai","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bioorg.2023.106933_b0130","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.ajpath.2013.01.048","article-title":"Inhibition of ATP Citrate Lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact","volume":"182","author":"Migita","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bioorg.2023.106933_b0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","article-title":"ATP citrate lyase inhibition can suppress tumor cell growth","volume":"8","author":"Hatzivassiliou","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2023.106933_b0140","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1158\/1535-7163.MCT-12-0095","article-title":"ATP Citrate Lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms","volume":"11","author":"Zaidi","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2023.106933_b0145","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/cddis.2013.215","article-title":"ATP citrate lyase knockdown impacts cancer stem cells in vitro","volume":"4","author":"Hanai","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2023.106933_b0150","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1101\/gad.283283.116","article-title":"Cullin3\u2013KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression","volume":"30","author":"Zhang","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2023.106933_b0155","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-Citrate Lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2023.106933_b0160","first-page":"1010","article-title":"ATP citrate lyase is increased in human breast cancer, depletion of which promotes apoptosis","volume":"39","author":"Wang","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bioorg.2023.106933_b0165","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1158\/0008-5472.CAN-15-1646","article-title":"Cyclin E associates with the lipogenic enzyme ATP-Citrate Lyase to enable malignant growth of breast cancer cells","volume":"76","author":"Lucenay","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2023.106933_b0170","first-page":"1943","article-title":"MiR-22 down-regulates the proto-oncogene ATP citrate lyase to inhibit the growth and metastasis of breast cancer","volume":"10","author":"Liu","year":"2018","journal-title":"Am. J. Translat. Res."},{"key":"10.1016\/j.bioorg.2023.106933_b0175","first-page":"25223","article-title":"mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2\/PIK3CA-hyperactive breast cancer","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2023.106933_b0180","first-page":"44251","article-title":"miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer","volume":"7","author":"Mei","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2023.106933_b0185","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.lungcan.2015.03.004","article-title":"Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer","volume":"88","author":"Osugi","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bioorg.2023.106933_b0190","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ejca.2004.12.037","article-title":"Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma","volume":"41","author":"Yahagi","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bioorg.2023.106933_b0195","doi-asserted-by":"crossref","first-page":"13379","DOI":"10.1016\/S0021-9258(18)90705-2","article-title":"Binding of ATP citrate lyase to the microsomal fraction of rat liver","volume":"259","author":"Linn","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0200","first-page":"6967","article-title":"Overexpression of ATP citrate lyase in renal cell carcinoma tissues and its effect on the human renal carcinoma cells in vitro","volume":"15","author":"Teng","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bioorg.2023.106933_b0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/bj2720181","article-title":"The effect of (-)-hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line HepG2","volume":"272","author":"Havekes","year":"1990","journal-title":"Biochem. J"},{"key":"10.1016\/j.bioorg.2023.106933_b0210","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/jcmm.16235","article-title":"ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2alpha\/ATF4\/CHOP axis","volume":"25","author":"Zheng","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bioorg.2023.106933_b0215","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10637-010-9552-x","article-title":"Adding a combination of hydroxycitrate and lipoic acid (Metabloc) to chemotherapy improves effectiveness against tumor development: experimental results and case report","volume":"30","author":"Guais","year":"2012","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.bioorg.2023.106933_b0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13046-018-0872-6","article-title":"Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours","volume":"37","author":"Nwosu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2023.106933_b0225","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3892\/or.2012.1638","article-title":"Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer","volume":"27","author":"Wang","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bioorg.2023.106933_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.742374","article-title":"Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway","volume":"11","author":"Wei","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2023.106933_b0235","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1038\/ncomms13525","article-title":"Amplification of USP13 drives ovarian cancer metabolism","volume":"7","author":"Han","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2023.106933_b0240","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.cmet.2018.04.015","article-title":"The BCKDH kinase and phosphatase integrate BCAA and lipid metabolism via regulation of ATP-Citrate Lyase","volume":"27","author":"White","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.bioorg.2023.106933_b0245","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41419-022-04606-1","article-title":"Nanog mediated by FAO\/ACLY signaling induces cellular dormancy in colorectal cancer cells","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2023.106933_b0250","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1158\/1078-0432.CCR-19-1359","article-title":"ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition","volume":"26","author":"Guo","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2023.106933_b0255","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1158\/1535-7163.MCT-13-0098","article-title":"ATP citrate lyase mediates resistance of colorectal cancer cells to SN38","volume":"12","author":"Zhou","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2023.106933_b0260","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3892\/or_00000778","article-title":"A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results","volume":"23","author":"Schwartz","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bioorg.2023.106933_b0265","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2021.04.024","article-title":"Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer","volume":"513","author":"Dai","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2023.106933_b0270","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3390\/cancers11121971","article-title":"ACLY (ATP Citrate Lyase) mediates radioresistance in head and neck squamous cell carcinomas and is a novel predictive radiotherapy biomarker","volume":"11","author":"Gottgens","year":"2019","journal-title":"Cancers (basel)"},{"key":"10.1016\/j.bioorg.2023.106933_b0275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12020-022-03124-6","article-title":"ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells","volume":"78","author":"Huang","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.bioorg.2023.106933_b0280","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1016\/S0021-9258(17)41006-4","article-title":"Reactivity and inhibitor potential of hydroxycitrate isomers with citrate synthase, citrate lyase, and ATP citrate lyase","volume":"252","author":"Sullivan","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0285","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0031-9422(00)86224-X","article-title":"(-)-Hydroxycitric acid-the principal acid in the fruits of Garcinia cambogia desr","volume":"4","author":"Lewis","year":"1965","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bioorg.2023.106933_b0290","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0003-9861(69)90532-3","article-title":"Lowenstein, Tricarballylate and Hydroxycitrate: of ATP: citrate substrate oxaloacetate and inhibitor lyase","volume":"135","author":"John","year":"1969","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2023.106933_b0295","first-page":"889","article-title":"Synthesis and evaluation of (+) and (-)-2,2-difluorocitrate as inhibitors of rat-liver ATP-citrate lyase and porcine-heart aconitase","volume":"202","author":"Barbara","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bioorg.2023.106933_b0300","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/14728222.2017.1303484","article-title":"Therapeutic effects of methionine sulfoximine in multiple diseases include and extend beyond inhibition of glutamine synthetase","volume":"21","author":"Brusilow","year":"2017","journal-title":"Expert Opin. Ther. Tar."},{"key":"10.1016\/j.bioorg.2023.106933_b0305","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1432-1033.1991.tb16105.x","article-title":"ATP-citrate lyase from rat liver characterisation of the citryl-enzyme complexes","volume":"199","author":"Wells","year":"1991","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bioorg.2023.106933_b0310","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1021\/jm00003a016","article-title":"Synthesis of novel thiol-containing citric acid analogs. kinetic evaluation of these and other potential active-site-directed and mechanism-based inhibitors of ATP Citrate Lyase","volume":"38","author":"Dolle","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0315","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/jm960167w","article-title":"ATP-Citrate Lyase as a target for hypolipidemic intervention. design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme","volume":"39","author":"Gribble","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0320","unstructured":"Smith-Kline Beecham PLC. Phenylderivative as inhibitors of ATP citrate lyase. WO9322304. 1993."},{"key":"10.1016\/j.bioorg.2023.106933_b0325","first-page":"113","article-title":"The role of ATP citrate-lyase in the metabolic regulation of plasma lipids Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076","volume":"334","author":"Nigel","year":"1998","journal-title":"Biochem. J"},{"key":"10.1016\/j.bioorg.2023.106933_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276579","article-title":"Inhibiting glutamine utilization creates a synthetic lethality for suppression of ATP citrate lyase in KRas-driven cancer cells","volume":"17","author":"Hatipoglu","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2023.106933_b0335","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1021\/jm00129a010","article-title":"Synthesis and hypolipidemic and antidiabetogenic activities of tetrasubstituted, long-chain dioic acids","volume":"32","author":"Tana","year":"1989","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0340","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.1016\/S0021-9258(17)39488-7","article-title":"Inhibition of lipid synthesis by beta beta'-tetramethyl-substituted, C14\u2013C22, alpha, omega-dicarboxylic acids in the rat in vivo","volume":"260","author":"Bar-Tana","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0345","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0005-2760(90)90018-S","article-title":"Inhibition of rat liver acetyl-CoA carboxylase by tetramethyl-substituted hexadecanedioic acid (MEDICA 16)","volume":"1042","author":"Kale","year":"1990","journal-title":"Biochimica Et Biophysics Acta"},{"key":"10.1016\/j.bioorg.2023.106933_b0350","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0005-2760(89)90083-0","article-title":"Alkylthioacetic acid (3-thia fatty acids) -a new group of non-\u03b2-oxidizable, peroxisome-inducing fatty acid analogues. I. A study on the structural requirements for proliferation of peroxisomes and mitochondria in rat liver","volume":"1004","author":"Berge","year":"1989","journal-title":"Biochim. Biophys. Acta (BBA) - Lipids Lipid Metabol."},{"key":"10.1016\/j.bioorg.2023.106933_b0355","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.ATV.13.11.1580","article-title":"Effect of 3-thiadicarboxylic acid on lipid metabolism in experimental nephrosis","volume":"13","author":"Shurbaji","year":"1993","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bioorg.2023.106933_b0360","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1038\/ncomms13457","article-title":"Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis","volume":"7","author":"Pinkosky","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2023.106933_b0365","first-page":"35","article-title":"Anthrones, naturally occurring competitive inhibitors of adenosine-triphosphate-citrate lyase, Drug Develop","volume":"36","author":"Joseph","year":"1995","journal-title":"Philos. Phenomenol. Res."},{"key":"10.1016\/j.bioorg.2023.106933_b0370","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ejmech.2016.12.018","article-title":"Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase","volume":"126","author":"Koerner","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0375","article-title":"Luteolin, a flavonoid, as an anticancer agent: A review","volume":"112","author":"Imran","year":"2019","journal-title":"Biomed. Pharma."},{"key":"10.1016\/j.bioorg.2023.106933_b0380","doi-asserted-by":"crossref","first-page":"10747","DOI":"10.3390\/ijms231810747","article-title":"Discovery of flavonoids as novel inhibitors of ATP Citrate Lyase: structure-activity relationship and inhibition profiles","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.106933_b0385","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7164\/antibiotics.50.729","article-title":"Antimycin, Inhibitors of ATP-Citrate Lyase, from a Streptomyces sp","volume":"50","author":"Cooper","year":"1997","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bioorg.2023.106933_b0390","doi-asserted-by":"crossref","first-page":"39231","DOI":"10.1074\/jbc.M006192200","article-title":"Radicicol binds and inhibits mammalian ATP citrate lyase","volume":"275","author":"Kish","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0395","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.2337\/diabetes.51.7.2018","article-title":"Critical Role for Cataplerosis via Citrate in Glucose-Regulated Insulin Release","volume":"51","author":"Flamez","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bioorg.2023.106933_b0400","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1039\/C9CC00256A","article-title":"Dehydrocurvularin is a potent antineoplastic agent irreversibly blocking ATP-citrate lyase: evidence from chemoproteomics","volume":"55","author":"Deng","year":"2019","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.bioorg.2023.106933_b0405","first-page":"15","article-title":"The hypolipidemic effects of 2-Furoic acid in Sprague-Dawley Rats","volume":"326","author":"Iris","year":"1992","journal-title":"Arch. Pharm. (weinheint)"},{"key":"10.1016\/j.bioorg.2023.106933_b0410","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.bmcl.2017.01.001","article-title":"Discovery of furan carboxylate derivatives as novel inhibitors of ATP-citrate lyase via virtual high-throughput screening","volume":"27","author":"Jernigan","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106933_b0415","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tips.2019.04.008","article-title":"Discovery of allosteric inhibition of human ATP-citrate lyase","volume":"40","author":"Granchi","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2023.106933_b0420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00109-019-01863-0","article-title":"The vital role of ATP citrate lyase in chronic diseases","volume":"98","author":"Khwairakpam","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bioorg.2023.106933_b0425","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1074\/jbc.M114.551051","article-title":"Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation","volume":"289","author":"Dufort","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0430","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jcim.2c00345","article-title":"Discovery of a novel macrocyclic ATP Citrate Lyase inhibitor","volume":"62","author":"Zang","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2023.106933_b0435","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1021\/jo00061a031","article-title":"Purpurone, an Inhibitor of ATP-Citrate Lyase: A novel alkaloid from the marine sponge iotrochota sp","volume":"58","author":"George","year":"1993","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0440","article-title":"Examining the genomic influence of skin antioxidants in vitro","volume":"201","author":"Gruber","year":"2010","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bioorg.2023.106933_b0445","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3382\/ps\/pey315","article-title":"Curcumin supplementation regulates lipid metabolism in broiler chickens","volume":"98","author":"Xie","year":"2019","journal-title":"Poult. Sci."},{"key":"10.1016\/j.bioorg.2023.106933_b0450","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1186\/s12937-017-0293-y","article-title":"Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials","volume":"16","author":"Qin","year":"2017","journal-title":"Nutr. J."},{"key":"10.1016\/j.bioorg.2023.106933_b0455","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.canlet.2014.03.015","article-title":"Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth","volume":"349","author":"Gao","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2023.106933_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2019.112184","article-title":"Phytochemical and biological studies on rare and endangered plants endemic to China. Part XV. Structurally diverse diterpenoids and sesquiterpenoids from the vulnerable conifer Pseudotsuga sinensis","volume":"169","author":"Huang","year":"2020","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bioorg.2023.106933_b0465","first-page":"137","article-title":"Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans4-isopropylcyclohexanecarbonyl)-D-phenylalanine","volume":"120","author":"Ikenoue","year":"1997","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106933_b0470","article-title":"Identification of lignans as ATP citrate lyase (ACLY) inhibitors from the roots of Pouzolzia zeylanica","volume":"1\u20138","author":"Li","year":"2023","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bioorg.2023.106933_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106381","article-title":"Enantiomeric pairs of macrocyclic acylphloroglucinols from syzygium szemaoense","volume":"132","author":"Huang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106933_b0480","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3892\/or.2022.8469","article-title":"Combined inhibition of ACLY and CDK4\/6 reduces cancer cell growth and invasion","volume":"49","author":"Velez","year":"2023","journal-title":"Oncol. Rep."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823005941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823005941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:46:14Z","timestamp":1758617174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823005941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":96,"alternative-id":["S0045206823005941"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106933","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advance of ATP citrate lyase inhibitors for the treatment of cancer and related diseases","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106933"}}